Ratings DuPont de Nemours, Inc. London S.E.

Equities

0A6B

US26614N1028

Real-time Estimate Cboe BZX Other stock markets 15:13:01 17/06/2024 BST			5-day change	1st Jan Change
79.44 ^USD	-0.25%		-0.76%	+3.75%

06-13	DuPont Launches New Tedlar® Frontsheet Offerings At 2024 Snec Pv Power Expo	CI
06-07	Declaration of Voting Results by DuPont de Nemours, Inc	CI

Summary

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Sales forecast by analysts have been recently revised upwards.
For several months, analysts have been revising their EPS estimates roughly upwards.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
The opinion of analysts covering the stock has improved over the past four months.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The company benefits from high valuations in earnings multiples.
The company's enterprise value to sales, at 3.15 times its current sales, is high.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the past year, analysts have significantly revised downwards their profit estimates.
Over the past twelve months, analysts' opinions have been revised negatively.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Diversified Chemicals

	1st Jan change	Capi.	ESG Refinitiv
DUPONT DE NEMOURS, INC.	+3.75%	33.31B	-
SHIN-ETSU CHEMICAL CO., LTD.	+0.44%	77.9B	B
BASF SE	-8.08%	42.56B	A-
PIDILITE INDUSTRIES LIMITED	+14.54%	18.93B	B
EASTMAN CHEMICAL COMPANY	+9.95%	11.7B	A-
BRENNTAG SE	-22.11%	10.04B	B
SYENSQO SA/NV	-6.96%	9.94B	-
ASAHI KASEI CORPORATION	-3.90%	8.89B	A-
SRF LIMITED	-3.12%	8.53B	C-
MITSUBISHI CHEMICAL GROUP CORPORATION	-6.85%	7.37B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes